Strata Skin Sciences Debt to Equity Ratio 2011-2025 | SSKN
Current and historical debt to equity ratio values for Strata Skin Sciences (SSKN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Strata Skin Sciences debt/equity for the three months ending September 30, 2025 was 10.22.
| Strata Skin Sciences Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-09-30 | $0.03B | $0.00B | 22.38 |
| 2025-06-30 | $0.03B | $0.00B | 98.75 |
| 2025-03-31 | $0.03B | $0.00B | 11.84 |
| 2024-12-31 | $0.03B | $0.01B | 6.03 |
| 2024-09-30 | $0.03B | $0.01B | 3.30 |
| 2024-06-30 | $0.03B | $0.01B | 3.17 |
| 2024-03-31 | $0.03B | $0.01B | 3.25 |
| 2023-12-31 | $0.03B | $0.01B | 2.31 |
| 2023-09-30 | $0.03B | $0.02B | 1.91 |
| 2023-06-30 | $0.04B | $0.02B | 2.27 |
| 2023-03-31 | $0.03B | $0.02B | 1.54 |
| 2022-12-31 | $0.03B | $0.02B | 1.39 |
| 2022-09-30 | $0.03B | $0.02B | 1.44 |
| 2022-06-30 | $0.03B | $0.02B | 1.40 |
| 2022-03-31 | $0.03B | $0.02B | 1.32 |
| 2021-12-31 | $0.02B | $0.03B | 0.83 |
| 2021-09-30 | $0.02B | $0.03B | 0.79 |
| 2021-06-30 | $0.02B | $0.03B | 0.74 |
| 2021-03-31 | $0.02B | $0.02B | 0.90 |
| 2020-12-31 | $0.02B | $0.03B | 0.81 |
| 2020-09-30 | $0.02B | $0.03B | 0.82 |
| 2020-06-30 | $0.02B | $0.03B | 0.73 |
| 2020-03-31 | $0.02B | $0.03B | 0.64 |
| 2019-12-31 | $0.02B | $0.03B | 0.65 |
| 2019-09-30 | $0.02B | $0.03B | 0.65 |
| 2019-06-30 | $0.02B | $0.03B | 0.63 |
| 2019-03-31 | $0.02B | $0.03B | 0.58 |
| 2018-12-31 | $0.02B | $0.03B | 0.52 |
| 2018-09-30 | $0.01B | $0.03B | 0.38 |
| 2018-06-30 | $0.01B | $0.03B | 0.37 |
| 2018-03-31 | $0.02B | $0.02B | 0.86 |
| 2017-12-31 | $0.02B | $0.02B | 0.97 |
| 2017-09-30 | $0.02B | $0.02B | 0.67 |
| 2017-06-30 | $0.03B | $0.01B | 2.69 |
| 2017-03-31 | $0.03B | $0.01B | 2.43 |
| 2016-12-31 | $0.03B | $0.02B | 1.94 |
| 2016-09-30 | $0.03B | $0.02B | 1.71 |
| 2016-06-30 | $0.03B | $0.02B | 1.57 |
| 2016-03-31 | $0.03B | $0.02B | 2.16 |
| 2015-12-31 | $0.03B | $0.02B | 2.11 |
| 2015-09-30 | $0.04B | $0.02B | 2.29 |
| 2015-06-30 | $0.03B | $0.03B | 1.00 |
| 2015-03-31 | $0.01B | $0.01B | 1.15 |
| 2014-12-31 | $0.01B | $0.01B | 0.64 |
| 2014-09-30 | $0.01B | $0.02B | 0.60 |
| 2014-06-30 | $0.01B | $0.01B | 0.75 |
| 2014-03-31 | $0.01B | $0.01B | 1.73 |
| 2013-12-31 | $0.01B | $0.01B | 0.70 |
| 2013-09-30 | $0.00B | $0.01B | 0.28 |
| 2013-06-30 | $0.01B | $0.02B | 0.52 |
| 2013-03-31 | $0.01B | $0.02B | 0.36 |
| 2012-12-31 | $0.00B | $0.01B | 0.24 |
| 2012-09-30 | $0.00B | $0.02B | 0.15 |
| 2012-06-30 | $0.00B | $0.02B | 0.13 |
| 2012-03-31 | $0.00B | $0.02B | 0.07 |
| 2011-12-31 | $0.00B | $0.03B | 0.05 |
| 2011-09-30 | $0.00B | $0.02B | 0.08 |
| 2011-06-30 | $0.00B | $0.02B | 0.06 |
| 2011-03-31 | $0.00B | $0.03B | 0.07 |
| 2010-12-31 | $0.00B | $0.03B | 0.06 |
| 2010-09-30 | $0.00B | $0.04B | 0.05 |
| 2010-06-30 | $0.00B | $0.03B | 0.07 |
| 2010-03-31 | $0.00B | $0.03B | 0.05 |
| 2009-12-31 | $0.00B | $0.03B | 0.06 |
| 2009-09-30 | $0.00B | $0.03B | 0.06 |
| 2009-06-30 | $0.00B | $0.01B | 0.18 |
| 2009-03-31 | $0.00B | $0.01B | 0.13 |
| 2008-12-31 | $0.00B | $0.02B | 0.10 |
| 2008-09-30 | $0.00B | $0.02B | 0.11 |
| 2008-06-30 | $0.00B | $0.01B | 0.17 |
| 2008-03-31 | $0.00B | $0.02B | 0.11 |
| 2007-12-31 | $0.00B | $0.02B | 0.06 |
| 2007-09-30 | $0.00B | $0.02B | 0.04 |
| 2007-06-30 | $0.00B | $0.02B | 0.06 |
| 2007-03-31 | $0.00B | $0.02B | 0.06 |
| 2006-12-31 | $0.00B | $0.02B | 0.06 |
| 2006-09-30 | $0.00B | $0.01B | 0.06 |
| 2006-06-30 | $0.00B | $0.01B | 0.07 |
| 2006-03-31 | $0.00B | $0.02B | 0.07 |
| 2005-12-31 | $0.00B | $0.02B | 0.05 |
| 2005-09-30 | $0.01B | $-0.01B | -1.42 |
| 2005-06-30 | $0.00B | 0.00 | |
| 2005-03-31 | $0.00B | 0.00 | |
| 2004-09-30 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.008B | $0.034B |
| Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.670B | 43.57 |
| Tempus AI (TEM) | United States | $13.356B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $8.623B | 70.15 |
| Doximity (DOCS) | United States | $8.480B | 34.92 |
| IRhythm Technologies (IRTC) | United States | $5.554B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $4.070B | 67.34 |
| Hinge Health (HNGE) | United States | $3.912B | 0.00 |
| Privia Health (PRVA) | United States | $2.974B | 186.00 |
| Heartflow (HTFL) | United States | $2.390B | 0.00 |
| 10x Genomics (TXG) | United States | $2.218B | 0.00 |
| Omnicell (OMCL) | United States | $1.973B | 40.34 |
| Azenta (AZTA) | United States | $1.679B | 68.87 |
| Enovis (ENOV) | United States | $1.582B | 8.31 |
| Clover Health Investments (CLOV) | United States | $1.374B | 0.00 |
| Schrodinger (SDGR) | United States | $1.322B | 0.00 |
| Phreesia (PHR) | United States | $0.951B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.842B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.770B | 0.00 |
| Claritev (CTEV) | United States | $0.578B | 0.00 |
| Standard BioTools (LAB) | United States | $0.565B | 0.00 |
| CapsoVision (CV) | United States | $0.553B | 0.00 |
| Talkspace (TALK) | United States | $0.540B | 108.67 |
| Veradigm (MDRX) | United States | $0.530B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.436B | 0.00 |
| Evolent Health (EVH) | United States | $0.433B | 0.00 |
| Carlsmed (CARL) | United States | $0.338B | 0.00 |
| TruBridge (TBRG) | United States | $0.336B | 15.43 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.314B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.287B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.273B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.187B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.168B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.161B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.146B | 0.00 |
| CareCloud (CCLD) | United States | $0.140B | 7.70 |
| Pulmonx (LUNG) | United States | $0.101B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.081B | 0.00 |
| Outset Medical (OM) | United States | $0.080B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.074B | 0.00 |
| American Well (AMWL) | United States | $0.067B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.066B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.053B | 0.00 |
| Precipio (PRPO) | United States | $0.042B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.036B | 0.00 |
| 111 (YI) | China | $0.033B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.028B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Zhongchao (ZCMD) | China | $0.015B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.015B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| PROFUSA (PFSA) | United States | $0.011B | 0.00 |
| Movano (MOVE) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.007B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |